NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Caplight Logo









Zymergen

Zymergen

Public
Emeryville, CaliforniaBiotechwww.zymergen.com

Last Round

Bankruptcy

Oct 3, 2023

Total Funding Raised

$1.76B

Company Overview

Zymergen is a biotechnology and materials science company that creates innovative microbe-based inputs and technologies for agricultural and industrial applications.

Sector

Biotech

AI Layer

Infrastructure

Keywords

automated synthetic biology platformmicrobe engineering for molecule manufacturingML-guided microbe engineeringsynthetic biology R&D servicesbio-manufactured materialsbio-manufactured polyimide filmdrug discovery from natural productsrobotic automation for biological R&Dhigh-throughput screening platformbio-based products for electronicsbio-based crop protection solutions

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Zymergen Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Zymergen Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
BankruptcyOct 3, 2023
M&AOct 19, 2022
IPO AnnouncedApr 26, 2021
Series DSep 8, 2020
Series CDec 13, 2018
Series B
Oct 11, 2016
View all Funding Rounds

Zymergen Investors

Notable investors and investment history

InvestorRounds
Andreessen HorowitzSeries B
SoftBank Investment AdvisersSeries D, Series C
Threshold VenturesSeries A
ICONIQ CapitalSeries B
Perceptive AdvisorsSeries D
Union Square VenturesSeries A
Innovation EndeavorsSeries B, Series C, Series A
View all Investors

Zymergen Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Zymergen Filings

SEC and related filings with document metadata.

Firmographic Details

HeadquartersEmeryville, California
Year Founded2013
Last FundingOct 3, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.





Caplight Logo




ProductsSecondary Data & TradingCaplight MarketPrice™Company DatabaseInvestor DatabaseSourcingAPI & MCP

Use CasesInvestorsEmployees

ResourcesResearch & BlogAboutCareers

LegalPrivacy PolicyTerms of UseBrokerCheckForm CRS


Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.